{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:06Z","timestamp":1786981266673,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CHRU de Tours"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>No psychotropic treatment has recognized effects on the core clinical signs of autism. In this retrospective study, we sought to identify predictors of psychotropic medication in autistic adults among demographic, diagnostic and functional clinical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 391 records of adults (28.2\u2009\u00b1\u20099.6 years) from the Centre de Ressources Autisme Centre Val de Loire were included. Participants were divided into three groups: those with Autism Spectrum Disorder (ASD) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009129), those with Intellectual and Developmental Disabilities (IDD) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200948), and those with both diagnoses (ASD\u2009+\u2009IDD) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009214). Multinomial logistic regression analyses were performed to assess factors associated with psychotropic pharmacotherapy in autistic adults.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>17% of autistic adults without IDD and 44.9% of autistic adults with IDD were prescribed multiple psychotropic medications. The first regression analysis showed that the likelihood of psychotropic polypharmacotherapy increases with age, epilepsy and severe externalizing behavior disorders. Anxiety disorders were associated with psychotropic monopharmacotherapy and mood disorders were a significant predictor to both mono and polypharmacotherapy. The second regression analysis highlighted that IDD is an explanatory factor for psychotropic polypharmacotherapy and ASD\u2009+\u2009IDD is predictive for both mono and polypharmacotherapy. Adults with ASD\u2009+\u2009IDD are prescribed more psychotropic medication than those with ASD alone, particularly antiepileptics, benzodiazepines and neuroleptics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study shows that co-occurring IDD, older age, epilepsy, anxiety and mood disorders, and externalizing behavioral disorders predict psychotropic medication use in autistic adults. The prevalence and the predictors of polymedication in this group raise concerns, emphasizing the need to develop new psychoeducational support and advance more targeted and effective treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10803-025-06966-x","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T19:44:23Z","timestamp":1754336663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of Psychotropic Medication Use Among Autistic Adults"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4771-2935","authenticated-orcid":false,"given":"Oc\u00e9ane","family":"Mah\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-2516","authenticated-orcid":false,"given":"Shasha","family":"Morel-Kohlmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4290-1478","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Briend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-7144","authenticated-orcid":false,"given":"Emmanuelle","family":"Houy-Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"5","key":"6966_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1023\/a:1025883612879","volume":"33","author":"MG Aman","year":"2003","unstructured":"Aman, M. G., Lam, K. S. L., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the autism society of Ohio. Journal of Autism and Developmental Disorders, 33(5), 527\u2013534. https:\/\/doi.org\/10.1023\/a:1025883612879","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6966_CR2","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"6966_CR3","unstructured":"Amestoy, E. (2017). La prescription de psychotropes chez les adultes avec trouble du spectre de l\u2019Autisme: \u00e9tat des connaissances et \u00e9tude descriptive [Th\u00e8se, M\u00e9decine humaine et pathologie]. https:\/\/dumas.ccsd.cnrs.fr\/dumas-01598125"},{"issue":"3","key":"6966_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/s0013-7006(05)82394-2","volume":"31","author":"A Baghdadli","year":"2005","unstructured":"Baghdadli, A., Gonnier, V., Valancogne, F., & Aussilloux, C. (2005). \u00c9tude descriptive de l\u2019utilisation de psychotropes Chez les personnes autistes de 20 \u00e0 35 Ans En institution du Languedoc-Roussillon. L\u2019Enc\u00e9phale, 31(3), 302\u2013308. https:\/\/doi.org\/10.1016\/s0013-7006(05)82394-2","journal-title":"L\u2019Enc\u00e9phale"},{"issue":"2","key":"6966_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/a:1025887723360","volume":"27","author":"C Barth\u00e9l\u00e9my","year":"1997","unstructured":"Barth\u00e9l\u00e9my, C., Roux, S., Adrien, J. L., Hameury, L., Gu\u00e9rin, P., Garreau, B., Fermanian, J., & Lelord, G. (1997). Validation of the revised behavior summarized evaluation scale. Journal of Autism and Developmental Disorders, 27(2), 139\u2013153. https:\/\/doi.org\/10.1023\/a:1025887723360","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"11","key":"6966_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00787-009-0028-5","volume":"18","author":"Y Bourreau","year":"2009","unstructured":"Bourreau, Y., Roux, S., Gomot, M., Bonnet-Brilhault, F., & Barth\u00e9l\u00e9my, C. (2009). Validation of the repetitive and restricted behaviour scale in autism spectrum disorders. European Child & Adolescent Psychiatry, 18(11), 675\u2013682. https:\/\/doi.org\/10.1007\/s00787-009-0028-5","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"2","key":"6966_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/b:jadd.0000022606.97580.19","volume":"34","author":"E Bradley","year":"2004","unstructured":"Bradley, E., Summers, J., Wood, H., & Bryson, S. E. (2004). Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism. Journal of Autism and Developmental Disorders, 34(2), 151\u2013161. https:\/\/doi.org\/10.1023\/b:jadd.0000022606.97580.19","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"7","key":"6966_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10803-006-0125-y","volume":"36","author":"AV Brereton","year":"2006","unstructured":"Brereton, A. V., Tonge, B. J., & Einfeld, S. L. (2006). Psychopathology in children and adolescents with autism compared to young people with intellectual disability. Journal of Autism and Developmental Disorders, 36(7), 863\u2013870. https:\/\/doi.org\/10.1007\/s10803-006-0125-y","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"12","key":"6966_CR17","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s10803-014-2170-2","volume":"44","author":"TR Buck","year":"2014","unstructured":"Buck, T. R., Viskochil, J., Farley, M., Coon, H., McMahon, W. M., Morgan, J., & Bilder, D. A. (2014). Psychiatric comorbidity and medication use in adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(12), 3063\u20133071. https:\/\/doi.org\/10.1007\/s10803-014-2170-2","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"14","key":"6966_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carri\u00e8re","year":"2009","unstructured":"Carri\u00e8re, I., Fourrier-Reglat, A., Dartigues, J. F., Rouaud, O., Pasquier, F., Ritchie, K., & Ancelin, M. L. (2009). Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study. Archives of Internal Medicine, 169(14), 1317\u20131324.","journal-title":"Archives of Internal Medicine"},{"issue":"12","key":"6966_CR19","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1007\/s10803-015-2553-z","volume":"45","author":"PE Cervantes","year":"2015","unstructured":"Cervantes, P. E., & Matson, J. L. (2015). Comorbid symptomology in adults with autism spectrum disorder and intellectual disability. Journal of Autism and Developmental Disorders, 45(12), 3961\u20133970. https:\/\/doi.org\/10.1007\/s10803-015-2553-z","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"Supplement_2","key":"6966_CR20","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1542\/peds.2012-0900d","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(Supplement_2), S69\u2013S76. https:\/\/doi.org\/10.1542\/peds.2012-0900d","journal-title":"Pediatrics"},{"issue":"7","key":"6966_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/1362361315577517","volume":"19","author":"LA Croen","year":"2015","unstructured":"Croen, L. A., Zerbo, O., Qian, Y., Massolo, M. L., Rich, S., Sidney, S., & Kripke, C. (2015). The health status of adults on the autism spectrum. Autism, 19(7), 814\u2013823. https:\/\/doi.org\/10.1177\/1362361315577517","journal-title":"Autism"},{"key":"6966_CR22","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"SB De Gage","year":"2014","unstructured":"De Gage, S. B., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., & B\u00e9gaud, B. (2014). Benzodiazepine use and risk of alzheimer\u2019s disease: Case-control study. Bmj, 349, g5205.","journal-title":"Bmj"},{"key":"6966_CR23","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.1003","author":"S Deb","year":"2021","unstructured":"Deb, S., Roy, M., Lee, R., Majid, M., Limbu, B., Santambrogio, J., Roy, A., & Bertelli, M. O. (2021). Randomised controlled trials of antidepressant and anti-anxiety medications for people with autism spectrum disorder: systematic review and meta-analysis. BJPsych Open. https:\/\/doi.org\/10.1192\/bjo.2021.1003","journal-title":"BJPsych Open"},{"issue":"6","key":"6966_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00787-015-0780-7","volume":"25","author":"J Downs","year":"2015","unstructured":"Downs, J., Hotopf, M., Ford, T., Simonoff, E., Jackson, R., Shetty, H., Stewart, R., & Hayes, R. D. (2015). Clinical predictors of antipsychotic use in children and adolescents with autism spectrum disorders: A historical open cohort study using electronic health records. European Child & Adolescent Psychiatry, 25(6), 649\u2013658. https:\/\/doi.org\/10.1007\/s00787-015-0780-7","journal-title":"European Child & Adolescent Psychiatry"},{"issue":"9","key":"6966_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10803-009-0750-3","volume":"39","author":"AJ Esbensen","year":"2009","unstructured":"Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and Non-Psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(9), 1339\u20131349. https:\/\/doi.org\/10.1007\/s10803-009-0750-3","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"6","key":"6966_CR25","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10803-019-03903-7","volume":"49","author":"A Esler","year":"2019","unstructured":"Esler, A., Hewitt, A., Hall-Lande, J., Pettingell, S. L., & Houseworth, J. (2019). Psychotropic medication use for adults with autism spectrum disorder who receive services and supports through adult developmental disability services in the united States. Journal of Autism and Developmental Disorders, 49(6), 2291\u20132303. https:\/\/doi.org\/10.1007\/s10803-019-03903-7","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"6966_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","volume":"73","author":"C Farmer","year":"2013","unstructured":"Farmer, C., Thurm, A., & Grant, P. (2013). Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research. Drugs, 73(4), 303\u2013314. https:\/\/doi.org\/10.1007\/s40265-013-0021-7","journal-title":"Drugs"},{"key":"6966_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psychres.2019.04.013","volume":"276","author":"L Fusar-Poli","year":"2019","unstructured":"Fusar-Poli, L., Brondino, N., Rocchetti, M., Petrosino, B., Arillotta, D., Damiani, S., Provenzani, U., Petrosino, C., Aguglia, E., & Politi, P. (2019). Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in italy: A cross-sectional study. Psychiatry Research, 276, 203\u2013209. https:\/\/doi.org\/10.1016\/j.psychres.2019.04.013","journal-title":"Psychiatry Research"},{"issue":"3","key":"6966_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.evopsy.2022.05.002","volume":"87","author":"P Gabbai","year":"2022","unstructured":"Gabbai, P., & Garreau, B. (2022). L\u2019avanc\u00e9e En \u00e2ge des personnes Atteintes de troubles du spectre de l\u2019autisme. \u00c9l\u00e9ments cliniques et psychopathologiques. L\u2019\u00c9volution Psychiatrique, 87(3), 525\u2013536. https:\/\/doi.org\/10.1016\/j.evopsy.2022.05.002","journal-title":"L\u2019\u00c9volution Psychiatrique"},{"issue":"1","key":"6966_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09540261.2018.1458706","volume":"30","author":"R Goel","year":"2018","unstructured":"Goel, R., Hong, J. J., Findling, R. L., & Ji, N. Y. (2018). An update on pharmacotherapy of autism spectrum disorder in children and adolescents. International Review of Psychiatry, 30(1), 78\u201395. https:\/\/doi.org\/10.1080\/09540261.2018.1458706","journal-title":"International Review of Psychiatry"},{"issue":"3","key":"6966_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015). Cumulative use of strong anticholinergics and incident dementia. JAMA Internal Medicine, 175(3), 401. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663","journal-title":"JAMA Internal Medicine"},{"issue":"5","key":"6966_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2105\/ajph.2017.303696","volume":"107","author":"J Guan","year":"2017","unstructured":"Guan, J., & Li, G. (2017). Injury mortality in individuals with autism. American Journal of Public Health, 107(5), 791\u2013793. https:\/\/doi.org\/10.2105\/ajph.2017.303696","journal-title":"American Journal of Public Health"},{"issue":"3","key":"6966_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1192\/bjp.bp.114.160192","volume":"208","author":"T Hirvikoski","year":"2016","unstructured":"Hirvikoski, T., Mittendorfer-Rutz, E., Boman, M., Larsson, H., Lichtenstein, P., & B\u00f6lte, S. (2016). Premature mortality in autism spectrum disorder. The British Journal of Psychiatry, 208(3), 232\u2013238. https:\/\/doi.org\/10.1192\/bjp.bp.114.160192","journal-title":"The British Journal of Psychiatry"},{"issue":"6","key":"6966_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00213-013-3263-x","volume":"231","author":"Y Hsia","year":"2013","unstructured":"Hsia, Y., Wong, A., Murphy, D., Simonoff, E., Buitelaar, J. K., & Wong, I. C. K. (2013). Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): A multinational study. Psychopharmacology (Berl), 231(6), 999\u20131009. https:\/\/doi.org\/10.1007\/s00213-013-3263-x","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"6966_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2016","unstructured":"Jobski, K., H\u00f6fer, J., Hoffmann, F., & Bachmann, C. (2016). Use of psychotropic drugs in patients with autism spectrum disorders: A systematic review. Acta Psychiatrica Scandinavica, 135(1), 8\u201328. https:\/\/doi.org\/10.1111\/acps.12644","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"6966_CR34","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s10803-012-1679-5","volume":"43","author":"G Joshi","year":"2012","unstructured":"Joshi, G., Wozniak, J., Petty, C., Martelon, M. K., Fried, R., Bolfek, A., Kotte, A., Stevens, J., Furtak, S. L., Bourgeois, M., Caruso, J., Caron, A., & Biederman, J. (2012). Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: A comparative study. Journal of Autism and Developmental Disorders, 43(6), 1314\u20131325. https:\/\/doi.org\/10.1007\/s10803-012-1679-5","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"6966_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pcl.2011.10.005","volume":"59","author":"G Kaplan","year":"2012","unstructured":"Kaplan, G., & McCracken, J. T. (2012). Psychopharmacology of autism spectrum disorders. Pediatric Clinics of North America, 59(1), 175\u2013187. https:\/\/doi.org\/10.1016\/j.pcl.2011.10.005","journal-title":"Pediatric Clinics of North America"},{"key":"6966_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-5-27","author":"D Kats","year":"2013","unstructured":"Kats, D., Payne, L., Parlier, M., & Piven, J. (2013). Prevalence of selected clinical problems in older adults with autism and intellectual disability. Journal of Neurodevelopmental Disorders. https:\/\/doi.org\/10.1186\/1866-1955-5-27","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"5","key":"6966_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/bf02172140","volume":"24","author":"JE Lainhart","year":"1994","unstructured":"Lainhart, J. E., & Folstein, S. E. (1994). Affective disorders in people with autism: A review of published cases. Journal of Autism and Developmental Disorders, 24(5), 587\u2013601. https:\/\/doi.org\/10.1007\/bf02172140","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"6966_CR37","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.rasd.2012.03.005","volume":"6","author":"JK Lake","year":"2012","unstructured":"Lake, J. K., Balogh, R., & Lunsky, Y. (2012). Polypharmacy profiles and predictors among adults with autism spectrum disorders. Research in Autism Spectrum Disorders, 6(3), 1142\u20131149. https:\/\/doi.org\/10.1016\/j.rasd.2012.03.005","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"9","key":"6966_CR38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1089\/cap.2014.0011","volume":"24","author":"JK Lake","year":"2014","unstructured":"Lake, J. K., Weiss, J. A., Dergal, J., & Lunsky, Y. (2014). Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder. Journal of Child and Adolescent Psychopharmacology, 24(9), 486\u2013493. https:\/\/doi.org\/10.1089\/cap.2014.0011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"6966_CR72","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/104454602762599853","volume":"12(4)","author":"K. S. Langworthy-Lam","year":"2002","unstructured":"Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina. Journal Of Child And Adolescent Psychopharmacology, 12(4), 311\u2011321. https:\/\/doi.org\/10.1089\/104454602762599853","journal-title":"Journal Of Child And Adolescent Psychopharmacology"},{"issue":"6","key":"6966_CR39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bpsc.2017.06.008","volume":"2","author":"AC Linke","year":"2017","unstructured":"Linke, A. C., Olson, L., Gao, Y., Fishman, I., & M\u00fcller, R. A. (2017). Psychotropic medication use in autism spectrum disorders May affect functional brain connectivity. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2(6), 518\u2013527. https:\/\/doi.org\/10.1016\/j.bpsc.2017.06.008","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"4","key":"6966_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/cap.2013.0119","volume":"25","author":"S Logan","year":"2015","unstructured":"Logan, S., Carpenter, L. A., Leslie, R. S., Garrett-Mayer, E., Hunt, K. J., Charles, J. M., & Nicholas, J. S. (2015). Aberrant behaviors and co-occurring conditions as predictors of psychotropic polypharmacy among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 25(4), 323\u2013336. https:\/\/doi.org\/10.1089\/cap.2013.0119","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"11","key":"6966_CR41","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1007\/s10803-014-2156-0","volume":"44","author":"S Logan","year":"2014","unstructured":"Logan, S., Carpenter, L. A., Leslie, R. S., Hunt, K., Garrett-Mayer, E., Charles, J. M., & Nicholas, J. S. (2014). Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 44(11), 2931\u20132948. https:\/\/doi.org\/10.1007\/s10803-014-2156-0","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6966_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/384527","author":"C Lopata","year":"2013","unstructured":"Lopata, C., Toomey, J. A., Fox, J. D., Thomeer, M. L., Volker, M. A., & Lee, G. K. (2013). Prevalence and predictors of psychotropic use in children with high-functioning ASDs. Autism Research and Treatment. https:\/\/doi.org\/10.1155\/2013\/384527","journal-title":"Autism Research and Treatment"},{"issue":"5","key":"6966_CR43","doi-asserted-by":"publisher","first-page":"659685","DOI":"10.1007\/bf02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord, C., Rutter, M., & Couteur, A. L. (1994). Autism diagnostic Interview-Revised A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659685. https:\/\/doi.org\/10.1007\/bf02172145","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6966_CR44","doi-asserted-by":"crossref","unstructured":"Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (1999). ADOS. Autism diagnostic observation schedule. Manual. WPS.","DOI":"10.1037\/t17256-000"},{"key":"6966_CR45","unstructured":"Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule, (ADOS-2) modules 1\u20134. Western Psychological Services."},{"key":"6966_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.rasd.2018.12.004","volume":"59","author":"J Lugo-Mar\u00edn","year":"2018","unstructured":"Lugo-Mar\u00edn, J., Mag\u00e1n-Maganto, M., Rivero-Santana, A., Cuellar-Pompa, L., Alviani, M., Jenaro-Rio, C., D\u00edez, E., & Canal-Bedia, R. (2018). Prevalence of psychiatric disorders in adults with autism spectrum disorder: A systematic review and meta-analysis. Research in Autism Spectrum Disorders, 59, 22\u201333. https:\/\/doi.org\/10.1016\/j.rasd.2018.12.004","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"4","key":"6966_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/acn3.51736","volume":"10","author":"AS Mai","year":"2023","unstructured":"Mai, A. S., Yau, C. E., Tseng, F. S., Foo, Q. X. J., Wang, D. Q., & Tan, E. (2023). Linking autism spectrum disorders and parkinsonism: Clinical and genetic association. Annals of Clinical and Translational Neurology, 10(4), 484\u2013496. https:\/\/doi.org\/10.1002\/acn3.51736","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"3","key":"6966_CR48","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1542\/peds.2007-0984","volume":"121","author":"DS Mandell","year":"2008","unstructured":"Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J. A., & Polsky, D. (2008). Psychotropic medication use among Medicaid-Enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441\u2013e448. https:\/\/doi.org\/10.1542\/peds.2007-0984","journal-title":"Pediatrics"},{"issue":"1","key":"6966_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.rasd.2010.04.004","volume":"5","author":"JL Matson","year":"2010","unstructured":"Matson, J. L., & Hess, J. A. (2010). Psychotropic drug efficacy and side effects for persons with autism spectrum disorders. Research in Autism Spectrum Disorders, 5(1), 230\u2013236. https:\/\/doi.org\/10.1016\/j.rasd.2010.04.004","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"1","key":"6966_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10882-007-9078-0","volume":"20","author":"JL Matson","year":"2007","unstructured":"Matson, J. L., & Rivet, T. T. (2007). The effects of severity of autism and PDD-NOS symptoms on challenging behaviors in adults with intellectual disabilities. Journal of Developmental and Physical Disabilities, 20(1), 41\u201351. https:\/\/doi.org\/10.1007\/s10882-007-9078-0","journal-title":"Journal of Developmental and Physical Disabilities"},{"issue":"2","key":"6966_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ridd.2009.10.009","volume":"31","author":"J McCarthy","year":"2010","unstructured":"McCarthy, J., Hemmings, C., Kravariti, E., Dworzynski, K., Holt, G., Bouras, N., & Tsakanikos, E. (2010). Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders. Research in Developmental Disabilities, 31(2), 362\u2013366. https:\/\/doi.org\/10.1016\/j.ridd.2009.10.009","journal-title":"Research in Developmental Disabilities"},{"issue":"5","key":"6966_CR51","doi-asserted-by":"publisher","first-page":"e1312e1321","DOI":"10.1542\/peds.2011-0427","volume":"127","author":"ML McPheeters","year":"2011","unstructured":"McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011). A systematic review of medical treatments for children with autism spectrum disorders. PEDIATRICS, 127(5), e1312e1321. https:\/\/doi.org\/10.1542\/peds.2011-0427","journal-title":"PEDIATRICS"},{"key":"6966_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00617","author":"S Miot","year":"2019","unstructured":"Miot, S., Akbaraly, T., Michelon, C., Couderc, S., Crepiat, S., Loubersac, J., Picot, M., Pernon, \u00c9., Gonnier, V., Jeandel, C., Blain, H., & Baghdadli, A. (2019). Comorbidity burden in adults with autism spectrum disorders and intellectual disabilities\u2014A report from the EFAAR (frailty assessment in ageing adults with autism spectrum and intellectual disabilities) study. Frontiers in Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2019.00617","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"6966_CR53","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/13623613221121623","volume":"27","author":"S Miot","year":"2023","unstructured":"Miot, S., Chancel, R., Peries, M., Crepiat, S., Couderc, S., Pernon, E., Picot, M. C., Gonnier, V., Jeandel, C., Blain, H., & Baghdadli, A. (2023). Multimorbidity patterns and subgroups among autistic adults with intellectual disability: Results from the EFAAR study. Autism, 27(3), 762\u2013777. https:\/\/doi.org\/10.1177\/13623613221121623","journal-title":"Autism"},{"issue":"8","key":"6966_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1177\/1362361313498518","volume":"18","author":"SS Mire","year":"2013","unstructured":"Mire, S. S., Nowell, K. P., Kubiszyn, T., & Goin-Kochel, R. P. (2013). Psychotropic medication use among children with autism spectrum disorders within the Simons simplex collection: Are core features of autism spectrum disorder related? Autism, 18(8), 933\u2013942. https:\/\/doi.org\/10.1177\/1362361313498518","journal-title":"Autism"},{"issue":"4","key":"6966_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10803-005-5030-2","volume":"35","author":"GH Murphy","year":"2005","unstructured":"Murphy, G. H., Beadle-Brown, J., Wing, L., Gould, J., Shah, A., & Holmes, N. (2005). Chronicity of challenging behaviours in people with severe intellectual disabilities and\/or autism: A total population sample. Journal of Autism and Developmental Disorders, 35(4), 405\u2013418. https:\/\/doi.org\/10.1007\/s10803-005-5030-2","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"2","key":"6966_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.30637\/2022.21-062","volume":"43","author":"E Mwali","year":"2022","unstructured":"Mwali, E., & Delvenne, V. (2022). Update on medical treatment of autism spectrum disorder. Revue Medicale De Bruxelles, 43(2), 135\u2013144. https:\/\/doi.org\/10.30637\/2022.21-062","journal-title":"Revue Medicale De Bruxelles"},{"issue":"11","key":"6966_CR56","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1517\/14656566.8.11.1579","volume":"8","author":"SM Myers","year":"2007","unstructured":"Myers, S. M. (2007). The status of pharmacotherapy for autism spectrum disorders. Expert Opinion on Pharmacotherapy, 8(11), 1579\u20131603. https:\/\/doi.org\/10.1517\/14656566.8.11.1579","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"6966_CR57","doi-asserted-by":"publisher","first-page":"110326","DOI":"10.1016\/j.pnpbp.2021.110326","volume":"110","author":"AM Persico","year":"2021","unstructured":"Persico, A. M., Ricciardello, A., Lamberti, M., Turriziani, L., Cucinotta, F., Brogna, C., Vitiello, B., & Arango, C. (2021). The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 110, 110326. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110326","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"6966_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00001163-200601000-00004","volume":"19","author":"D Powell","year":"2006","unstructured":"Powell, D., Dunlap, G., & Fox, L. (2006). Prevention and intervention for the challenging behaviors of toddlers and preschoolers. Infants & Young Children, 19, 25\u201335.","journal-title":"Infants & Young Children"},{"key":"6966_CR59","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/"},{"issue":"3","key":"6966_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10803-009-0878-1","volume":"40","author":"RE Rosenberg","year":"2009","unstructured":"Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, K., Marvin, A. R., & Law, P. A. (2009). Psychotropic medication use among children with autism spectrum disorders enrolled in a National registry, 2007\u20132008. Journal of Autism and Developmental Disorders, 40(3), 342\u2013351. https:\/\/doi.org\/10.1007\/s10803-009-0878-1","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6966_CR60","unstructured":"RStudio Team (2020). PBC, Boston, MA URL http:\/\/www.rstudio.com\/"},{"issue":"6","key":"6966_CR61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1023\/b:jadd.0000005995.02453.0b","volume":"33","author":"MM Seltzer","year":"2003","unstructured":"Seltzer, M. M., Krauss, M. W., Shattuck, P. T., Orsmond, G., Swe, A., & Lord, C. (2003). The symptoms of autism spectrum disorders in adolescence and adulthood. Journal of Autism and Developmental Disorders, 33(6), 565\u2013581. https:\/\/doi.org\/10.1023\/b:jadd.0000005995.02453.0b","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"6966_CR62","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","volume":"12","author":"D Shash","year":"2016","unstructured":"Shash, D., Kurth, T., Bertrand, M., Dufouil, C., Barberger-Gateau, P., Berr, C., & Tzourio, C. (2016). Benzodiazepine, psychotropic medication, and dementia: A population\u2010based cohort study. Alzheimer\u2019s & Dementia, 12(5), 604\u2013613.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"6966_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ajmg.1320600105","volume":"60","author":"SL Smalley","year":"1995","unstructured":"Smalley, S. L., McCracken, J. T., & Tanguay, P. E. (1995). Autism, affective disorders, and social phobia. American Journal of Medical Genetics, 60(1), 19\u201326. https:\/\/doi.org\/10.1002\/ajmg.1320600105","journal-title":"American Journal of Medical Genetics"},{"issue":"5","key":"6966_CR63","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1542\/peds.2012-3774","volume":"132","author":"D Spencer","year":"2013","unstructured":"Spencer, D., Marshall, J., Post, B., Kulakodlu, M., Newschaffer, C. J., Dennen, T., Azocar, F., & Jain, A. (2013). Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics, 132(5), 833\u2013840. https:\/\/doi.org\/10.1542\/peds.2012-3774","journal-title":"Pediatrics"},{"key":"6966_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-015-9125-6","author":"S Starkstein","year":"2015","unstructured":"Starkstein, S., Gellar, S., Parlier, M., Payne, L., & Piven, J. (2015). High rates of Parkinsonism in adults with autism. Journal of Neurodevelopmental Disorders. https:\/\/doi.org\/10.1186\/s11689-015-9125-6","journal-title":"Journal of Neurodevelopmental Disorders"},{"issue":"6","key":"6966_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0163-8343(01)00164-5","volume":"23","author":"J Stolker","year":"2001","unstructured":"Stolker, J., Heerdink, E. R., Leufkens, H. G. M., Clerkx, M., & Nolen, W. A. (2001). Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders. General Hospital Psychiatry, 23(6), 345\u2013349. https:\/\/doi.org\/10.1016\/s0163-8343(01)00164-5","journal-title":"General Hospital Psychiatry"},{"issue":"4","key":"6966_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ijnp\/pyab073","volume":"25","author":"F Torres-Bondia","year":"2021","unstructured":"Torres-Bondia, F., Dakterzada, F., Galv\u00e1n, L., Buti, M., Besanson, G., Grill, E., Buil, R., De Batlle, J., & Pi\u00f1ol-Ripoll, G. (2021). Benzodiazepine and Z-Drug use and the risk of developing dementia. The International Journal of Neuropsychopharmacology, 25(4), 261\u2013268. https:\/\/doi.org\/10.1093\/ijnp\/pyab073","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"6","key":"6966_CR66","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10803-006-0248-1","volume":"37","author":"E Tsakanikos","year":"2006","unstructured":"Tsakanikos, E., Costello, H., Holt, G., Sturmey, P., & Bouras, N. (2006). Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism. Journal of Autism and Developmental Disorders, 37(6), 1080\u20131085. https:\/\/doi.org\/10.1007\/s10803-006-0248-1","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"10","key":"6966_CR67","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/aur.2590","volume":"14","author":"G Vivanti","year":"2021","unstructured":"Vivanti, G., Tao, S., Lyall, K., Robins, D. L., & Shea, L. L. (2021). The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder. Autism Research, 14(10), 2189\u20132199. https:\/\/doi.org\/10.1002\/aur.2590","journal-title":"Autism Research"},{"issue":"4","key":"6966_CR68","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40801-016-0096-z","volume":"3","author":"R Vohra","year":"2016","unstructured":"Vohra, R., Madhavan, S., Sambamoorthi, U., StPeter, C., Poe, S. G., Dwibedi, N., & Ajmera, M. (2016). Prescription drug use and polypharmacy among Medicaid-Enrolled adults with autism: A retrospective Cross-Sectional analysis. Drugs - Real World Outcomes, 3(4), 409\u2013425. https:\/\/doi.org\/10.1007\/s40801-016-0096-z","journal-title":"Drugs - Real World Outcomes"},{"issue":"4","key":"6966_CR69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/cap.2005.15.671","volume":"15","author":"AN Witwer","year":"2005","unstructured":"Witwer, A. N., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 671\u2013681. https:\/\/doi.org\/10.1089\/cap.2005.15.671","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"6966_CR70","unstructured":"World Health Organization (2016). International statistical classification of diseases and related health problems (10th ed.). https:\/\/icd.who.int\/browse10\/2016\/en"},{"issue":"1","key":"6966_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaac.2020.03.007","volume":"60","author":"M Zhou","year":"2021","unstructured":"Zhou, M., Nasir, M., Farhat, L. C., Kook, M., Artuko\u011flu, B. B., & Bloch, M. H. (2021). Meta-analysis: Pharmacologic treatment of restricted and repetitive behaviors in autism spectrum disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 60(1), 35\u201345. https:\/\/doi.org\/10.1016\/j.jaac.2020.03.007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-025-06966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-025-06966-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-025-06966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:53:28Z","timestamp":1757350408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-025-06966-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":72,"alternative-id":["6966"],"URL":"https:\/\/doi.org\/10.1007\/s10803-025-06966-x","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"2 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}